Abstract Details
|
Neil Datta, MD
(Cambridge Health Alliance)
PRESENTER |
Dr. Datta has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint Global. Dr. Datta has received personal compensation in the range of $0-$499 for serving as a Consultant for Spherix Global. |
| Bhaskar Roy, MD, FAAN (Yale University) | Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Roy has stock in Cabaletta bio. . Dr. Roy has stock in Pfizer. Dr. Roy has stock in CAVA. The institution of Dr. Roy has received research support from Abcuro Pharmaceuticals. The institution of Dr. Roy has received research support from Immunovant. The institution of Dr. Roy has received research support from argenx. |
| Ekaterina Bakradze, MD (University of Alabama At Birmingham) | Dr. Bakradze has nothing to disclose. |
| David M. Waitzman, MD | No disclosure on file |